Collaborative Care Cuts Depressive Symptoms in Seniors

Share this content:
Collaborative Care Cuts Depressive Symptoms in Seniors
Collaborative Care Cuts Depressive Symptoms in Seniors

WEDNESDAY, Feb. 22, 2017 (HealthDay News) -- For older adults with subthreshold depression, collaborative care is associated with a reduction in depressive symptoms compared with usual care, according to a study published online Feb. 21 in the Journal of the American Medical Association.

Simon Gilbody, Ph.D., from the University of York in the United Kingdom, and colleagues randomized participants aged 65 years or older with Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) subthreshold depression to collaborative care (344 participants), which was coordinated by a case manager who assessed functional impairments relating to mood symptoms, or to a control group (361 participants) which received usual primary care.

The researchers found that at four-month follow-up, collaborative care resulted in lower 9-item Patient Health Questionnaire scores than usual care (mean, 5.36 versus 6.67; P < 0.001); at 12-month follow-up the corresponding scores were 5.93 and 7.25 (P = 0.001). At four-month follow-up, 17.2 and 23.5 percent of participants met criteria for depression (relative risk, 0.83; 95 percent confidence interval, 0.61 to 1.27; P = 0.25); at 12-month follow-up the corresponding proportions were 15.7 and 27.8 percent (relative risk, 0.65; 95 percent confidence interval, 0.46 to 0.91; P = 0.01).

"Among older adults with subthreshold depression, collaborative care compared with usual care resulted in a statistically significant difference in depressive symptoms at four-month follow-up, of uncertain clinical importance," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »